Northsea Therapeutics
NorthSea Therapeutics is a Pan-European biotech company
Northsea Therapeutics has raised €106M across 2 funding rounds from 8 investors, most recently a round in Dec 2021. Based in Naarden, Netherlands; founded 2017; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€106M
€106,412,798
Funding rounds
2
Investors
8
distinct backers
Active since
2020-01
latest 2021-12
Funding by year
EUR raised per yearNorthsea Therapeutics — funding by year — interactive chart.
Data table
| Northsea Therapeutics — funding by year | |
|---|---|
| 2020 | €36M |
| 2021 | €71M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood11
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▲ 9y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-12-17 | Other | €71M | BGV,Forbion,Forbion Growth,New Science Ventures,Novo Seeds,Sofinnova Partners+2 more | View deal → |
| 2020-01-08 | Series B | €36M | venBio Partners | View deal → |
Investors
8Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData